KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) Stock
KMTS has an Alpha Score of 51 out of 100 (weak), computed on Nov 10, 2026 from 2 of 4 sub-scores. Company insiders reported 0 open-market buys and 16 sales on SEC Form 4 in the 90 days to Nov 9, 2026.
What is KMTS's Alpha Score?
How it works →Alpha Score of 51 reflects moderate overall profile with strong momentum, weak quality. Based on 2 of 4 signals – score is capped at 75 until remaining data ingests.
Computed from 2 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Nov 10, 2026
A rules-based research rating, not a recommendation to buy or sell.
Are KESTRA MEDICAL TECHNOLOGIES, LTD. insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Nov 3, 26 | Moran Timothy P. | Chief Business Officer | SELL | 3.2K | $94K |
| Oct 29, 26 | Mahboob Vaseem | Chief Financial Officer | SELL | 4.8K | $147K |
| Oct 28, 26 | Mahboob Vaseem | Chief Financial Officer | SELL | 39.9K | $1.2M |
| Oct 27, 26 | Umberger Traci S | See Remarks | SELL | 30.0K | $901K |
| Oct 27, 26 | Mahboob Vaseem | Chief Financial Officer | SELL | 34.8K | $1.0M |
| Oct 21, 26 | Umberger Traci S | See Remarks | SELL | 96.4K | $2.6M |
| Oct 21, 26 | Umberger Traci S | See Remarks | SELL | 3.6K | $101K |
| Oct 20, 26 | Webster Brian Daniel | See Remarks | SELL | 13.3K | $393K |
| Oct 20, 26 | Webster Brian Daniel | See Remarks | SELL | 1.7K | $50K |
| Sep 30, 26 | Cohen Raymond W | Director | SELL | 3.3K | $98K |
SEC Form 4 filings as of Nov 9, 2026
See cluster-buy signals across all tickers →What are KMTS's key statistics?
Key statistics as of Nov 2, 2026
How does KMTS's valuation compare with the Healthcare sector?
| Metric | KMTS | Healthcare median | Companies in median |
|---|---|---|---|
| Net margin | -140.43% | 3.62% | 174 |
| Return on equity | -64.18% | 2.96% | 200 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 10, 2026). P/E excludes loss-making companies.
KMTS price chart
Powered by TradingViewWhat does KESTRA MEDICAL TECHNOLOGIES, LTD. do?
Kestra Medical Technologies Inc. is a company specializing in the development and production of innovative medical devices. The core function of Kestra is to design wearable medical technologies aimed at improving patient outcomes in critical health areas. Primarily, the company engages in creating devices that focus on cardiac care, providing solutions that monitor, diagnose, and assist in the management of heart conditions. Kestra Medical Technologies addresses significant needs within the healthcare sector, particularly impacting the cardiology field by offering devices that enhance both the quality and efficiency of patient care. As a player in the medical technology industry, Kestra is positioned to influence patient health management trends and contribute to the advancement of medical device technologies. Its products serve as critical tools for healthcare providers aiming to offer cutting-edge care solutions.